Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction

BACKGROUND: Arrhythmia is the foremost cause of sudden death after myocardial infarction (MI). Animal models have recently shown that erythropoietin (EPO) can reduce the incidence of arrhythmia after MI. METHODS: We investigated the effects of administrating 33,000 IU EPO on the occurrence of post-M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholamzadeh, Ali, Amini, Sara, Mohammadpour, Amir H., Vahabzadeh, Maryam, Fazelifar, Amir F., Fazlinezhad, Afsoon, Dehghani, Mashalla, Moohebati, Mohsen, Dastani, Mostafa, Malaekeh-Nikouie, Bizhan, Falsoleiman, Homa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461390/
https://www.ncbi.nlm.nih.gov/pubmed/25636071
http://dx.doi.org/10.1097/FJC.0000000000000223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461390/
https://www.ncbi.nlm.nih.gov/pubmed/25636071
http://dx.doi.org/10.1097/FJC.0000000000000223

Ejemplares similares